Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Abstract
alpha7-Nicotinic acetylcholine receptors (alpha7-nAChR) have been implicated in a range of cognitive deficits in schizophrenia. Therefore we examined alpha7-nAChR knockout (KO), heterozygote (HT) and wildtype (WT) littermate mice in the 5-CSR (a rodent model of sustained attention) and odour span (a novel mouse working memory paradigm) tasks, and related performance to nAChR density. Whilst there was no difference between groups in baseline 5-CSR task performance, alpha7-nAChR KO's exhibited significantly higher omission levels compared to WT mice on increasing the attentional load, with HT mice performing at an intermediate level. Furthermore, alpha7-nAChR KO mice were significantly impaired in the odour span task when compared to WT mice, in a pattern consistent with impaired attention. These behavioural deficits were associated with the loss of alpha7-nAChRs, as alpha4beta2-nAChR density was unaltered in these mice. Thus these studies intimate that the attentional impairment in alpha7-nAChR transgenic mice maybe core to other deficits in cognition.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Attentional impairments are seen in mice lacking the α7 nAChR.
“In contrast, attentional impairments were seen in mice lacking the α7 nAChR (Hoyle et al, 2006; Young et al, 2007).”
From Modes and models of forebrain cholinergic neuromodulation of cognition (2011) · cites this paper as Young et al, 2007
Cites
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry
Robbins, T. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1154-7 · Cited by 1,282 · see citing works
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · see citing works
Parasuraman, R. (1998) · Cited by 917 · see citing works
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678 · see citing works
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666 · see citing works
Langley, J. N. (1905) · The Journal of Physiology · doi:10.1113/jphysiol.1905.sp001128 · Cited by 608 · see citing works
Orr‐Urtreger, A., Göldner, F. M., Saeki, M., Lorenzo, I., Goldberg, L. B., Biasi, M. D., Dani, J. A., Patrick, J. W., & Beaudet, A. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09165.1997 · Cited by 494 · see citing works
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics
Adler, L. E., Hoffer, L., Griffith, J. M., Waldo, M. C., & Freedman, R. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90073-9 · Cited by 412 · see citing works
Le Novère, N., Corringer, P., & Changeux, J. (2002) · Journal of Neurobiology · doi:10.1002/neu.10153 · Cited by 411 · see citing works
Effects of nicotinic stimulation on cognitive performance
NEWHOUSE, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 401 · see citing works
Cognitive function in schizophrenia
Sharma, T., & Antonova, L. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(02)00084-9 · Cited by 367 · see citing works
Nicotinic receptor subtypes and cognitive function
Levin, E. D. (2002) · Journal of Neurobiology · doi:10.1002/neu.10151 · Cited by 354 · see citing works
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 340 · see citing works
Transdermal nicotine effects on attention
Levin, E. D., Conners, C. K., Silva, D., Hinton, S. C., Meck, W. H., March, J. S., & Rose, J. E. (1998) · Psychopharmacology · doi:10.1007/s002130050750 · Cited by 331 · see citing works
Selective α 7 -nicotinic agonists normalize inhibition of auditory response in DBA mice
Stevens, K. E., Kem, W. R., Mahnir, V. M., & Freedman, R. (1998) · Psychopharmacology · doi:10.1007/s002130050573 · Cited by 269 · see citing works
Marks, M. J., Stitzel, J. A., Romm, E., Wehner, J. M., & Collins, A. C. (1986) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10395-7 · Cited by 267 · see citing works
[3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza, L. A., Dhawan, S., & Kellar, K. J. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10925-5 · Cited by 264 · see citing works
Cholinergic gating of response to auditory stimuli in rat hippocampus
Luntz‐Leybman, V., Bickford, P. C., & Freedman, R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91437-j · Cited by 260 · see citing works
Rossi, F., Pizzorusso, T., Porciatti, V., Marubio, L. M., Maffei, L., & Changeux, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101120998 · Cited by 246 · see citing works
Davies, A. R. L., HARDICK, D. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., & Wonnacott, S. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00221-4 · Cited by 246 · see citing works
Grottick, A. J., & Higgins, G. A. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00305-3 · Cited by 240 · see citing works
KITAGAWA, H., TAKENOUCHI, T., Azuma, R., Wesnes, K. A., Kramer, W. G., Clody, D. E., & Burnett, A. L. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300028 · Cited by 238 · see citing works
Kem, W. R. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00211-4 · Cited by 233 · see citing works
Nicotine effects on brain function and functional connectivity in schizophrenia
Jacobsen, L. K., D’Souza, D. C., Mencl, W. E., Pugh, K. R., Skudlarski, P., & Krystal, J. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.023 · Cited by 233 · see citing works
Breese, C. R., Adams, C. E., Logel, J., Drebing, C. J., Rollins, Y. D., Barnhart, M. M., Sullivan, B. F., DeMasters, B. K., Freedman, R., & Leonard, S. S. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19971027)387:3 · Cited by 231 · see citing works
Blockade of Nicotine Self-Administration with Nicotinic Antagonists in Rats
Watkins, S. S., Epping-Jordan, M. P., Koob, G. F., & Markou, A. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00226-3 · Cited by 229 · see citing works
Hajós, M., Hurst, R. S., Hoffmann, W. E., Krause, M., Wall, T. M., Higdon, N. R., & Groppi, V. E. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076968 · Cited by 225 · see citing works
Young, J. W., Finlayson, K., Spratt, C., Marston, H. M., Crawford, N., Kelly, J. S., & Sharkey, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300393 · Cited by 219 · see citing works
Self-citationNeurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia
Cullum, C. M., Harris, J. G., Waldo, M. C., Smernoff, E., Madison, A., Nagamoto, H. T., Griffith, J., Adler, L. E., & Freedman, R. (1993) · Schizophrenia Research · doi:10.1016/0920-9964(93)90048-n · Cited by 212 · see citing works
Increased neurodegeneration during ageing in mice lacking high‐affinity nicotine receptors
Zoli, M., Picciotto, M. R., Ferrari, R., Cocchi, D., & Changeux, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1235 · Cited by 206 · see citing works
Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204 · see citing works
Stevens, K. E. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00178-g · Cited by 203 · see citing works
Arendash, G. W., Sengstock, G. J., Sanberg, P. R., & Kem, W. R. (1995) · Brain Research · doi:10.1016/0006-8993(94)01449-r · Cited by 198 · see citing works
Dudchenko, P. A., Wood, E. R., & Eichenbaum, H. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-08-02964.2000 · Cited by 198 · see citing works
AR-R 17779, an α7 nicotinic agonist, improves learning and memory in rats
Levin, E. D., Bettegowda, C., Blosser, J. C., & Gordon, J. C. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199911000-00014 · Cited by 193 · see citing works
Briggs, C., Anderson, D. J., Brioni, J., Buccafusco, J., Buckley, M., Campbell, J. E., Decker, M. W., Donnelly-Roberts, D., Elliott, R., Gopalakrishnan, M., et al. (1997) · Pharmacology, Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00354-1 · Cited by 190 · see citing works
Hahn, B., Shoaib, M., & Stolerman, I. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1005-6 · Cited by 188 · see citing works
Dépatie, L. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00372-x · Cited by 175 · see citing works
AR-R 17779 improves social recognition in rats by activation of nicotinic α7 receptors
van Kampen, M., Selbach, K., Schneider, R., Schiegel, E., Boess, F., & Schreiber, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1668-7 · Cited by 160 · see citing works
Differential Agonist Inhibition Identifies Multiple Epibatidine Binding Sites in Mouse Brain
Marks, M. J., Smith, K. W., & Collins, A. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37384-7 · Cited by 140 · see citing works
Attentional effects of nicotinic agonists in rats
Hahn, B., Sharples, C. G. V., Wonnacott, S., Shoaib, M., & Stolerman, I. P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00099-6 · Cited by 135 · see citing works
Stevens, K. E., & Wear, K. D. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00466-2 · Cited by 129 · see citing works
Tropisetron improves deficits in auditory P50 suppression in schizophrenia
Koike, K., Hashimoto, K., Takai, N., Shimizu, E., Komatsu, N., Watanabe, H., Nakazato, M., Okamura, N., Stevens, K. E., Freedman, R., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.016 · Cited by 126 · see citing works
Whiteaker, P., Davies, A. R. L., Marks, M. J., Blagbrough, I. S., Potter, B. V. L., Wolstenholme, A. J., Collins, A. C., & Wonnacott, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00685.x · Cited by 123 · see citing works
Chudasama, Y., & Robbins, T. W. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1805-y · Cited by 121 · see citing works
Simosky, J. K., Stevens, K. E., Adler, L. E., & Freedman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1285-x · Cited by 121 · see citing works
Effect of scopolamine on visual attention in rats
Jones, D. N. C., & Higgins, G. A. (1995) · Psychopharmacology · doi:10.1007/bf02246186 · Cited by 115 · see citing works
Selective effects of nicotine on attentional processes
Mancuso, G., Sherwood, N., Tirelli, E., Warburton, D. M., & M�len, M. (1999) · Psychopharmacology · doi:10.1007/s002130051107 · Cited by 106 · see citing works
Intragastric DMXB-A, an α7 nicotinic agonist, improves deficient sensory inhibition in DBA/2 mice
Simosky, J. K., Stevens, K. E., Kem, W. R., & Freedman, R. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01093-9 · Cited by 106 · see citing works
Greco, B., Invernizzi, R. W., & Carli, M. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2127-9 · Cited by 80 · see citing works
Evidence for the involvement of the hippocampus in the pathophysiology of schizophrenia
Gothelf, D., Soreni, N., Nachman, R., Tyano, S., Hiss, Y., Reiner, O., & Weizman, A. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00097-3 · Cited by 73 · see citing works
Franceschini, D., Paylor, R. E., Broide, R. S., Salas, R., Bassetto, L., Gotti, C., & Biasi, M. D. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00309-6 · Cited by 72 · see citing works
Turchi, J. N., & Sarter, M. F. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.01347.x · Cited by 72 · see citing works
Reversal of a Vigilance Decrement in the Aged Rat by Subtype-Selective Nicotinic Ligands
Grottick, A. J., Haman, M., Wyler, R., & Higgins, G. A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300102 · Cited by 68 · see citing works
Selective Nicotinic Receptor Consequences in APPSWE Transgenic Mice
Bednar, I., Paterson, D., Marutle, A., Pham, T. M., Svedberg, M. M., Hellström‐Lindahl, E., Mousavi, M. T., COURT, J. A., Morris, C. M., Perry, E. K., et al. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1112 · Cited by 65 · see citing works
Hashimoto, K., Iyo, M., Freedman, R., & Stevens, K. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0142-0 · Cited by 63 · see citing works
Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice
Gommans, J., Stolerman, I. P., & Shoaib, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00130-1 · Cited by 61 · see citing works
Maemoto, T., Finlayson, K., Olverman, H. J., Akahane, A., Horton, R. W., & Butcher, S. P. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701465 · Cited by 57 · see citing works
Self-citationDMXB, an ?7 nicotinic agonist, normalizes auditory gating in isolation-reared rats
O’Neill, H. C., Rieger, K., Kem, W. R., & Stevens, K. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1482-2 · Cited by 57 · see citing works
Keller, J. J., Keller, A. B., Bowers, B. J., & Wehner, J. M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.03.004 · Cited by 57 · see citing works
The role of nicotinic receptor α7 subunits in nicotine discrimination
Stolerman, I. P., Chamberlain, S. A. F., Bizarro, L., Fernandes, C., & Schalkwyk, L. C. (2003) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.10.002 · Cited by 56 · see citing works
Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti, C., Carbonnelle, E., Moretti, M., Zwart, R., & Clementi, F. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00212-6 · Cited by 55 · see citing works
Reversal of isolation-rearing-induced PPI deficits by an α7 nicotinic receptor agonist
Cilia, J., Cluderay, J. E., Robbins, M. J., Reavill, C., Southam, E., Kew, J. N. C., & Jones, D. N. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0069-5 · Cited by 53 · see citing works
Muir, J. L., Bussey, T. J., Everitt, B. J., & Robbins, T. W. (1996) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)81106-0 · Cited by 50 · see citing works
Tatsumi, R., Fujio, M., Satoh, H., Katayama, J., Takanashi, S.-I., Hashimoto, K., & Tanaka, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049188d · Cited by 47 · see citing works
Synthesizing Schizophrenia: A Bottom-Up, Symptomatic Approach
Robbins, T. W. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi044 · Cited by 39 · see citing works
Turchi, J. N., & Sarter, M. F. (2000) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2000.01347.x · Cited by 39 · see citing works
Freedman, R., Ross, R. G., Leonard, S. S., Myles‐Worsley, M., Adams, C. E., Waldo, M. C., Tregellas, J. R., Martín, L., D, A. O. M., Tanabe, J., et al. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.1/frreedman · Cited by 34 · see citing works
Léna, C., & Changeux, J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11333.x · Cited by 28 · see citing works
Grottick, A. J., Wyler, R., & Higgins, G. A. (2000) · Psychopharmacology · doi:10.1007/s002130000444 · Cited by 28 · see citing works
Genetic linkage to schizophrenia at chromosome 15q14
Freedman, R., & Leonard, S. S. (2001) · American Journal of Medical Genetics · doi:10.1002/ajmg.1548 · Cited by 27 · see citing works
S.15.04 The α7 nicotinic receptor as a potential peripheral marker for schizophrenia
Fuchs, S., Perl, O., Ilani, T., et al. (2004) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(04)80046-4 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Modes and models of forebrain cholinergic neuromodulation of cognition
Hasselmo, M. E., & Sarter, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.104 · Cited by 733 · see citing works
Prepulse inhibition and genetic mouse models of schizophrenia
Powell, S. B., Zhou, X., & Geyer, M. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.021 · Cited by 218 · see citing works
Parikh, V., Ji, J., Decker, M. W., & Sarter, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5712-09.2010 · Cited by 133 · see citing works
Livingstone, P. D., Srinivasan, J., Kew, J. N. C., Dawson, L. A., Gotti, C., Moretti, M., Shoaib, M., & Wonnacott, S. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06613.x · Cited by 133 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Gray, N. E., Zweig, J. A., Caruso, M., Martin, M. D., Zhu, J. Y., Quinn, J. F., & Soumyanath, A. (2018) · Brain and Behavior · doi:10.1002/brb3.1024 · Cited by 76 · see citing works
Young, J. W., Meves, J. M., & Geyer, M. A. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.028 · Cited by 69 · see citing works
Self-citationKogan, J. H., Gross, A. K., Featherstone, R. E., Shin, R., Chen, Q., Heusner, C. L., Adachi, M., Lin, A., Walton, N. M., Miyoshi, S., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3967-14.2015 · Cited by 59 · see citing works
Behavioral effects of PNU-282987, an alpha7 nicotinic receptor agonist, in mice
Vicens, P., Ribes, D., Torrente, M., & Domingo, J. L. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.015 · Cited by 39 · see citing works
Acheson, D. T., Twamley, E. W., & Young, J. W. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00103 · Cited by 26 · see citing works
Self-citation
- Authors
- Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J.
- Affiliations
- University of Edinburgh (GB)
- Corresponding author
- Finlayson, Keith
- Venue
- European Neuropsychopharmacology
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 17
- Issue
- 2
- Pages
- 145-155
- ISSN
- 0924-977X (ISSN-L)
- OpenAlex
- W2074915076
- Cited by
- 233
- References
- 74
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 1 · 2021: 4 · 2020: 6 · 2019: 9 · 2018: 9 · 2017: 11 · 2016: 17 · 2015: 19 · 2014: 18 · 2013: 27 · 2012: 20
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Astellas Foundation for Research on Metabolic Disorders
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- alpha7 nicotinic acetylcholine receptor, knockout mice, sustained attention, working memory, attentional load, omission errors, α4β2 nicotinic acetylcholine receptor, receptor density
- MeSH terms
- Quinolizidine Alkaloids, Aconitine, Alkaloids, Animals, Animals, Newborn, Attention Deficit Disorder with Hyperactivity, Azocines, Behavior, Animal, Choice Behavior, Cognition Disorders, Dose-Response Relationship, Drug, Protein Binding, Quinolizines, Reaction Time, Receptors, Nicotinic, Tritium, Mice, Knockout, Nicotinic Antagonists, Mice, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review